Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Pyroptosis and its relationship to atherosclerosis
Yuan-Jun Xu1, Lei Zheng1, Yan-Wei Hu1
1Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
Pyroptosis, a cell death form, involves inflammatory caspases and releases inflammatory signals. It is increasingly linked to atherosclerosis and lesion instability, warranting further investigation into its mechanisms.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Pyroptosis is a regulated, pro-inflammatory cell death pathway.
- It is dependent on inflammatory caspases and distinct from apoptosis and necrosis.
- Pyroptosis involves rapid plasma membrane rupture, releasing inflammatory mediators like IL-1β, IL-18, and HMGB-1.
Purpose of the Study:
- To review advancements in understanding pyroptosis.
- To elucidate the morphological, molecular, and pathophysiological mechanisms of pyroptosis.
- To explore the role of pyroptosis in atherosclerosis and atherosclerotic lesion instability.
Main Methods:
- Literature review of recent studies on pyroptosis.
- Analysis of morphological and molecular characteristics of pyroptosis.
- Examination of pathophysiological implications, particularly in atherosclerosis.
Main Results:
- Pyroptosis is characterized by specific morphological and molecular features.
- It triggers the release of key pro-inflammatory cytokines and alarmins.
- Emerging evidence suggests a significant role for pyroptosis in atherosclerosis development and progression.
Conclusions:
- Pyroptosis is a critical inflammatory cell death pathway.
- Its mechanisms are increasingly understood, highlighting its distinct nature.
- Pyroptosis is implicated in atherosclerotic lesion instability, suggesting therapeutic potential.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Inflammation
Atherosclerosis III: Management

